Economic Outcomes of Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention-Reference-Cited by-同舟云学术

Economic Outcomes of Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention

Published:2017-04 Issue:8 Volume:10 Page:774-782
ISSN:1936-8798
Container-title:JACC: Cardiovascular Interventions
language:en
Short-container-title:JACC: Cardiovascular Interventions

Author:

Baron Suzanne J.,Lei Yang,Chinnakondepalli Khaja,Vilain Katherine,Magnuson Elizabeth A.,Kereiakes Dean J.,Ellis Stephen G.,Stone Gregg W.,Cohen David J.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference31 articles.

1. Comparison of the safety between first- and second-generation drug eluting stents: meta-analysis from 19 randomized trials and 16,924 patients;Martin-Reyes;Int J Cardiol,2012

2. First-generation versus second-generation drug-eluting stents in current clinical practice: updated evidence from a comprehensive meta-analysis of randomised clinical trials comprising 31 379 patients;Navarese;Open Heart,2014

3. Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies;Kirtane;Circulation,2009

4. Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials;Bangalore;Circulation,2012

5. Long-term safety of drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis;Palmerini;J Am Coll Cardiol,2015

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioresorbable Vascular Scaffolds: Should We use Them Again?;International Journal of Cardiovascular Practice;2023-10-28

2. An Overview of In Vitro Drug Release Methods for Drug-Eluting Stents;Polymers;2022-07-05

3. Recent Least Burdensome Approach for the Approval of Innovative Medical Devices in Japan -Regulatory Approval Review of an Everolimus-eluting Bioresorbable Scaffold-;Internal Medicine;2021-01-15

4. The Application of Traditional Chinese Medicine Injection on Patients with Acute Coronary Syndrome during the Perioperative Period of Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials;Evidence-Based Complementary and Alternative Medicine;2020-05-19

5. Two-year clinical outcomes after implantation of an everolimus-eluting bioresorbable scaffold (Absorb) in stable angina and acute coronary syndrome patients. Single-centre real-life registry data;Advances in Interventional Cardiology;2018